Kanbergs Alexa N, Sullivan Mackenzie W, Maner Morgan, Brinkley-Rubinstein Lauren, Goodman Annekathryn, Davis Michelle, Feldman Sarah
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Division of Gynecologic Oncology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Division of Gynecologic Oncology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Am J Prev Med. 2023 Feb;64(2):244-249. doi: 10.1016/j.amepre.2022.09.021.
The objective of this study is to better understand cervical cancer screening and follow-up practices in U.S. prisons.
A 29-question survey examining cervical cancer screening practices, education, and facility/patient characteristics was disseminated to state-prison medical directors.
A total of 70% (35/50) of state medical directors completed the survey between August 2021 and January 2022. All prison systems provided cervical cancer screening both at intake and specified intervals. A total of 36% provided colposcopy on site, and 9% performed excisional procedures on site. A total of 11 states identified 1‒5 cases of cervical cancer within the last year. Frequently cited challenges included a perceived lack of patient interest, delays in community referral, and lack of follow-up of abnormal results after release.
This study found relatively high rates of screening with a perceived lack of patient interest as the most reported barrier. Follow-up care was also often affected by reported lack of patient interest, delays in community referral for diagnostic procedures, and patient release before follow-up. There is room for further optimization of screening and surveillance among incarcerated women by understanding and addressing systems-based challenges. By understanding patient barriers to primary screening, expanding access to onsite testing and community referral for abnormal results, and streamlining post-release follow-up, disparities in care among incarcerated women can be reduced.
本研究的目的是更好地了解美国监狱中的宫颈癌筛查及后续治疗情况。
向州监狱医疗主任发放了一份包含29个问题的调查问卷,内容涉及宫颈癌筛查做法、教育以及设施/患者特征。
在2021年8月至2022年1月期间,共有70%(35/50)的州医疗主任完成了调查。所有监狱系统在入狱时及特定间隔期都提供宫颈癌筛查。共有36%的系统在现场提供阴道镜检查,9%在现场进行切除手术。共有11个州在过去一年中发现了1至5例宫颈癌病例。经常提到的挑战包括患者兴趣明显不足、社区转诊延迟以及释放后对异常结果缺乏后续跟进。
本研究发现筛查率相对较高,但患者兴趣明显不足是最常报告的障碍。后续护理也常常受到患者兴趣不足、诊断程序社区转诊延迟以及患者在后续跟进前获释的影响。通过理解并应对基于系统的挑战,在被监禁女性中进一步优化筛查和监测仍有空间。通过了解患者进行初次筛查的障碍、扩大现场检测及针对异常结果进行社区转诊的机会,并简化释放后的后续跟进,可以减少被监禁女性在医疗护理方面的差异。